Every Thursday we send out a curated newsletter on “all things femtech”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page
“Dorsata’s advanced clinical rules engine improves diagnosis, treatment, and documentation making day-to-day patient care experience a delight while ensuring patients receive the right care at the right time.”
Highlights
Maternity management startup Dorsata closes a $5.2M Series A; The UN Population Fund warns the COVID-19 pandemic could have serious consequences for women’s health; Rhia Ventures presents a new issue brief about COVID-19 and Reproductive Health; Yes Health, a digital health service focused on nutrition counseling raises a $6M Series A; The FDA relaxes requirements for digital products helping patients with psychiatric disorders during the COVID-19 crisis; According to a recently published Crunchbase report, only 3% of business funding goes to women; With Covid-19 delaying routine care, chronic disease startups brace for a slew of complications; Rare disease drug research platform RDMD closes a $14M Series A
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on:
Kathrin Folkendt is the Founder & CEO of Femtech Insider, the globally leading publication on all things femtech. She usually writes about women's health innovation, health equity, and entrepreneurship.
